Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Health Economics and Outcomes Research
      • Integrated Commercial Solutions
      • Medical Affairs Transformation
      • Medical Communications
      • Medication Engagement
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Syndicated Market Research and Insights
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
      • Ophthalmology
      • Respiratory
      • Women's Health
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Realigning in Real Time
Trends

Realigning in Real Time

December 31, 2020
Content 

 

Subscribe to our Newsletter

Realigning in Real Time

2021 Health Trends
Columns 
Content 
Image or Video 

Realigning in Real Time

Realigning in Real Time
Content 

In response to the pandemic, many organizations have learned a new agility. The necessity of addressing radical disruption forced teams to evolve processes and approaches that typically would have required years of change management in mere weeks and months.

These sprints have led to everything from ways to expedite the start- up of clinical trials on COVID-19 treatments and vaccines to rapidly opening new digital channels and ways of work for commercial teams. As we move toward a next normal, companies are tallying the lessons learned and analyzing how to best use those ideas and experiences to continue evolution and change.

Critical Question

Of the changes made to effectively operate throughout the pandemic, which are likely to become an ongoing part of how we operate in any normal?

Sparks for Realigning in Real Time
Columns 
Content 
Image or Video 

10 Years of Growth_618.png

10 Years of Growth

10 Years: A recent analysis of e-Commerce penetration found that sector experienced the equivalent of 10 years of growth in the first 3 months of the pandemic.

— McKinsey Analysis, 2020
 

Content 
Image or Video 

Pivot - Patient Care.png

Pivot - Patient Care

Pivot: “It has taken a pandemic and a relentless virus for the medical community to start thinking critically about various aspects of patient care and clinical trials. Through the necessary reforms implemented for medicine to survive in the face of this crisis, we hope that we can find a silver lining in improving how we execute clinical trials going forward for the betterment of cancer patients.”

— JAMA Oncology, 2020
 

 

Download a PDF of this content below. 

 

The 2021 Health Trends Series
The Race to Return Safe
Remote Care
Download
Download

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Content

The 2021 Health Trends Series
December 1, 2020
The Race to Return Safe
December 17, 2020
Remote Care
December 1, 2020

Chapters

Chapter:
1
Remote Care
Chapter:
2
The Race to Return Safe
Chapter:
3
Realigning in Real Time
Chapter:
4
Post-Surge Capacity
Chapter:
5
The Next Normal
Chapter:
6
Fast Launch; Long Tail

Pages

  • 1
  • 2
  • next ›
  • last »
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

Contact Us
Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2021 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out